NCT01649401
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,753 public trials
646 recruiting studies
Hypersensitivity trial results
NCT01765192
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Berlin, Germany
- Großhansdorf, Germany
- Hamburg, Germany
- Hanover, Germany
NCT01856764
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Berlin, Germany
- Gera, Germany
- Hamburg, Germany
Completed
Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
NCT00392288
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- sanofi-aventis, US Bridgewater, New Jersey, United States
- Sanofi-Aventis Hungaria Budapest, Hungary
- Sanofi-Aventis México, Mexico
- sanofi-aventis Poland Warsaw, Poland
NCT02819102
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- Quotient Clinical Ltd Ruddington, Nottingham, United Kingdom
NCT01607372
- Conditions
- Asthma, Asthma and Rhinitis, Bronchial Diseases, +13 more
- Locations
-
- GSK Investigational Site Toronto, Ontario, Canada
NCT00980200
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Cypress, California, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Bethesda, Maryland, United States
- GSK Investigational Site Rolla, Missouri, United States
Completed
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
NCT01454544
- Conditions
- Dust Mite Allergy, House Dust Mite Allergy, Hypersensitivity, +9 more
- Locations
-
- Department of Respiratory Diseases, Lapeyronie Hospital Montpellier, France
Completed
Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma
NCT00414817
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Center for Health Research/KPH Honolulu, Hawaii, United States
- Center for Health Research-KPNW Portland, Oregon, United States
NCT01433523
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Universitätsklinikum Rostock, Abteilung für Pneumologie Zentrum für Innere Medizin, Ernst Heydemann Strasse 6 Rostock, Germany